AxoGen News

Axogen's Strong Growth Prospects and Positive Analyst Outlook Prompt Buy Rating and Increased Price Target

TipRanksMar 6 23:17 ET

Buy Rating Affirmed: AxoGen's Robust Growth and Market Potential Drive Positive Outlook

TipRanksMar 6 00:35 ET

Buy Rating Affirmed for AxoGen on Strong Clinical Results and Encouraging Sales Performance

TipRanksJan 22 15:17 ET

Axogen Analyst Ratings

BenzingaJan 19 09:23 ET

Analysts Offer Insights on Healthcare Companies: ScPharmaceuticals (SCPH), Alnylam Pharma (ALNY) and AxoGen (AXGN)

TipRanksJan 9 01:10 ET

Buy Rating Affirmed for AxoGen on Strong Growth and Promising Market Prospects

TipRanksJan 5 10:46 ET

Canaccord Genuity Reiterates Buy on Axogen, Maintains $11 Price Target

BenzingaDec 7, 2023 10:44 ET

Axogen Analyst Ratings

BenzingaDec 7, 2023 10:43 ET

Buoyant AxoGen Performance and Growth Prospects: A Buy Recommendation Analysis

TipRanksNov 8, 2023 01:12 ET

Leerink Partners Initiates Coverage On Axogen With Outperform Rating, Announces Price Target of $9

BenzingaOct 16, 2023 11:37 ET

Axogen Analyst Ratings

BenzingaOct 16, 2023 11:35 ET

Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $16 Price Target

BenzingaSep 26, 2023 11:42 ET

Axogen Analyst Ratings

BenzingaSep 26, 2023 11:40 ET

Cantor Fitzgerald Reiterates Overweight on Axogen, Maintains $16 Price Target

BenzingaAug 22, 2023 10:45 ET

Axogen Analyst Ratings

BenzingaAug 22, 2023 10:44 ET

JMP Securities Remains a Buy on AxoGen (AXGN)

TipRanksAug 8, 2023 00:35 ET

JMP Securities Reiterates Market Outperform on Axogen, Maintains $20 Price Target

BenzingaMay 10, 2023 08:35 ET

Analysts' Top Healthcare Picks: AxoGen (AXGN), Inhibrx (INBX)

TipRanksMay 10, 2023 01:21 ET

Analysts Offer Insights on Healthcare Companies: AxoGen (AXGN) and BioRestorative Therapies (BRTX)

TipRanksMay 9, 2023 12:16 ET

Canaccord Genuity Sticks to Their Buy Rating for AxoGen (AXGN)

TipRanksMar 28, 2023 08:41 ET